UA23352A - Beta-d-glucosammonia salt of alpha-bromisovaleric acid possessing antiviral activities against vesicular stomatitis virus, herpes simplex virus, and coronavirus
- Google Patents
Beta-d-glucosammonia salt of alpha-bromisovaleric acid possessing antiviral activities against vesicular stomatitis virus, herpes simplex virus, and coronavirus
Hауково-Дослідний Інститут Мікробіології Та Імунології Ім. І.І Мечнікова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Українська Фармацевтична Академія, Украинская фармацевтическая академия, Hауково-Дослідний Інститут Мікробіології Та Імунології Ім. І.І МечніковаfiledCriticalУкраїнська Фармацевтична Академія
Priority to UA96124563ApriorityCriticalpatent/UA23352A/en
Publication of UA23352ApublicationCriticalpatent/UA23352A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to the medicine, namely to the antiviral substances and may be used for treating vesicular stomatitis, herpes simplex, and coronavirus infection.
UA96124563A1996-12-051996-12-05Beta-d-glucosammonia salt of alpha-bromisovaleric acid possessing antiviral activities against vesicular stomatitis virus, herpes simplex virus, and coronavirus
UA23352A
(en)
Beta-d-glucosammonia salt of alpha-bromisovaleric acid possessing antiviral activities against vesicular stomatitis virus, herpes simplex virus, and coronavirus
Beta-d-glucosammonia salt of alpha-bromisovaleric acid possessing antiviral activities against vesicular stomatitis virus, herpes simplex virus, and coronavirus
Beta-d-glucosammonia salt of alpha-bromisovaleric acid possessing antiviral activities against vesicular stomatitis virus, herpes simplex virus, and coronavirus
Beta-d-glucosammonia salt of alpha-bromisovaleric acid possessing antiviral activities against vesicular stomatitis virus, herpes simplex virus, and coronavirus